Cargando…
Genetic modifiers ameliorate endocytic and neuromuscular defects in a model of spinal muscular atrophy
BACKGROUND: Understanding the genetic modifiers of neurodegenerative diseases can provide insight into the mechanisms underlying these disorders. Here, we examine the relationship between the motor neuron disease spinal muscular atrophy (SMA), which is caused by reduced levels of the survival of mot...
Autores principales: | Walsh, Melissa B., Janzen, Eva, Wingrove, Emily, Hosseinibarkooie, Seyyedmohsen, Muela, Natalia Rodriguez, Davidow, Lance, Dimitriadi, Maria, Norabuena, Erika M., Rubin, Lee L., Wirth, Brunhilde, Hart, Anne C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495824/ https://www.ncbi.nlm.nih.gov/pubmed/32938453 http://dx.doi.org/10.1186/s12915-020-00845-w |
Ejemplares similares
-
CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis
por: Janzen, Eva, et al.
Publicado: (2018) -
Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice
por: Strathmann, Eike A., et al.
Publicado: (2018) -
PLS3 Overexpression Delays Ataxia in Chp1 Mutant Mice
por: Janzen, Eva, et al.
Publicado: (2019) -
Mitochondrial Dysfunction in Spinal Muscular Atrophy
por: Zilio, Eleonora, et al.
Publicado: (2022) -
Dominant spinal muscular atrophy is caused by mutations in BICD2, an important golgin protein
por: Martinez-Carrera, Lilian A., et al.
Publicado: (2015)